Background: Pancreatic cancer is among the most lethal cancers worldwide due to the limited availability of techniques for early detection of signs and symptoms.
| INTRODUCTION
Due to the limited range of available diagnostic techniques for detecting the early signs and symptoms of pancreatic cancer, it has become the most lethal cancer worldwide and the fourth-leading cause of cancer-related mortality in Japanese adults.
Endoscopic ultrasound (EUS) is the most effective method for the management of pancreatic cancer; it leads to a higher diagnostic yield than ultrasonography, computed tomography, magnetic resonance imaging and polyethylene terephthalate for the detection of early pancreatic tumours. 1, 2 Endoscopic ultrasonography-guided fineneedle aspiration (EUS-FNA), as reported by Vilmann et al, 3 is often used for the qualitative preoperative diagnosis of tumours and for the assessment of medical treatment strategies. Recently, in addition to the increased use of EUS-FNA for the diagnosis of pancreatic lesions, the rate of cytological and histological examinations has also significantly increased in Japan. In the present study, we investigated samples obtained using EUS-FNA over 7 years in our hospital. We analysed the accuracy of cytological, histological and clinical diagnoses of cell-block-specimens to enhance diagnostic precision. A comparative examination of biopsy, cytological diagnosis, histological diagnosis and clinical diagnosis revealed that cytological diagnosis had a higher sensitivity for the detection of pancreatic cancer and other related malignancies than the other diagnostic methods.
| MATERIALS AND METHODS
Specimens from 165 patients with pancreatic lesions obtained using EUS-FNA between January 2010 and July 2016 at the Kyorin University Hospital were examined. The mean patient age was 68.7 (range, 34-86) years. In total, 86 males and 79 females were recruited in this case study. Both cytological and histological examinations were conducted on the samples collected using EUS-FNA. EUS-FNA was performed using 22-G processing needles with stylets. After tissue sampling, the needles were washed once with laboratory saline, and the resulting small tissue samples were fixed in bottles containing 15% formalin solution. We examined the small tissue samples as cell-block-specimens for histological diagnosis. For cytological examination, the needles were washed, and the samples obtained were transferred onto glass slides and preserved with 95% ethanol. The slides were submitted to the pathology laboratory for cytological examination using fixed smear and Diff-Quik staining techniques. Rapid on-site evaluation was performed on specific specimens as needed. Formalin-fixed samples submitted for histological diagnosis were processed in an automated tissue processor for approximately one night and were penetrated with paraffin liquid via de-ethanol and de-xylene staining. Subsequently, using machine processing, ethanol was replaced with paraffin, and the solution was then hand-stirred, subjected to pressure and further treated. Small tissue samples were wrapped with organic solvent-resistant sponges in a cassette as individual paraffin blocks.
Pancreatic cancer was diagnosed when it was suspected from clinical data, laboratory imaging findings, clinical diagnoses at our hospital and cytology/histology biopsy diagnoses of carcinoma and/or suspected carcinoma.
Based on clinician reports, the cytological and histological cellblock-specimens results from all 165 patients were classified into the following five categories: 'no malignancy', 'atypical cells', 'suspected carcinoma', 'carcinoma' and 'other malignancy'. The cytological and histological categories of each patient were subsequently compared. Patients who underwent surgery or chemotherapy as treatment were considered to have 'pancreatic cancer', whereas patients who were followed up due to a clinical diagnosis of no malignancy were considered to have a 'benign lesion'. Four patients who were diagnosed with malignant lymphomas were excluded. The cytological and histological reports and clinical diagnoses of these patients were compared to analyse the diagnostic accuracy of cytology ( Table 2 ). The results from the cytological, histological and clinical diagnoses were analysed to identify the clinical course and generate a comparison chart using the results from the cytological diagnoses.
| ETHICS
This study was performed in accordance with the Declaration of Hel- 
| RESULTS
Initially, cytological diagnoses were compared with the results from biopsy. For 93 of 161 patients (58%), the histological and cytological diagnoses were in complete accordance. Furthermore, carcinomas and suspected carcinomas were diagnosed through cytological and histological cell-block-specimens diagnoses in 81 patients (50%). Table 1 presents a comparison of the cytological and histological diagnoses.
Based on the results of the clinical diagnoses and a comparison
with the cytological/histological diagnoses, 153 patients were followed up to determine their clinical course, of which 5 were deemed to have atypical lesions. One patient was diagnosed with adenocarcinoma by cytology; however, after the diagnosis, this patient was confirmed by operation to have an atypical lesion ( Figure 4 ). Of the remaining 148 patients, malignancy was diagnosed in 138 patients, whereas malignancy was not established in the remaining 10 patients ( Table 2 ). The 10 patients are currently being followed up. Of the 138 patients diagnosed with pancreatic cancer, 31 were confirmed by operation to have a pathological diagnosis of adenocarcinoma. Ascites were detected in 5 of 138 patients, and the cytological diagnosis of these patients was adenocarcinoma. Four of them were confirmed by liver biopsy, and the histological diagnosis was adenocarcinoma. Other than the cases mentioned above, the imaging findings were confirmed.
Of the 138 patients, cytology revealed that 101 had malignancy, 32 had atypical cells and 5 had no malignancy. Of the five cases, one was discovered to have metastasis to the kidney, whereas for the remaining four, the malignancy was clear, and chemotherapy was given. Of the 101 patients identified with a malignancy, histological biopsy diagnoses confirmed malignancy in 90 patients, atypical cells in 9 patients and no malignancy in 2 patients ( Table 2 ). The example patients indicated in Table 2 
| DISCUSSION
Pancreatic tumours are defined as adenocarcinomas, which are primarily external secretion tumours that commonly develop from the pancreatic duct. 4 The cellular images of pancreatic cancer do not vary greatly from those of adenocarcinomas in other organs.
The histological cell-block-specimens of pancreatic tissue yield a small volume of tissue from the harvested material, resulting in a small yield of cells to derive any significant data. Nevertheless, the cytology samples obtained from our laboratory were enough to detect background necrosis, which is suggestive of malignancy. A diagnostic approach for the evaluation of pancreatic cancer (malignancy) was established based on biopsy findings; however, our results demonstrate that cytology was more effective in inferring malignant tumours. These findings emphasise the need for the sampling of both histology and cytology specimens during diagnosis. Thus, the significant information obtained from cytology suggests that it is the fundamental diagnostic approach for the assessment of pancreatic cancer.
Although malignancy can be established using biopsy analysis, cytological diagnosis (using FNA) is required for the identification of the variants of malignancy, highlighting the different sampling possibilities within tissue specimens. Although the same specimen was subjected to both cytological and histological biopsy diagnoses, the correlation of both tests was not significantly high. We considered that in some cases, cytological/histological examination findings and the uneven- Owing to its expense, on-site cytological diagnosis is not conducted at our hospital, 6 and the distance between the endoscopy room and pathology laboratory in our hospital may discourage the presence of an endoscopist. However, regulating the number of punctures is necessary for assessing tumour cells. 7 sample should be subjected to further testing. Generally, seven or eight cytotechnologists and pathologists are engaged in routine cytological diagnoses in our laboratory.
In the present study, formalin-fixed samples submitted for histological diagnosis were subjected to rigorous processing (as described in Section 2). However, this rigorous procedure is more likely to diminish the number of cells if the initial sample is small. To avoid this, the sample was wrapped with organic solvent-resistant sponges in a cassette as individual paraffin blocks. Small liquid components, such as necrotic materials, can be eluted by ethanol or xylene to consequently disappear during processing. The remaining components also often penetrate the exclusive sponge and are therefore not detected by encapsulation. Although immunostaining, which is enabled by a cytological diagnosis and executed via decolouration and transcription, can be used to study target cells, there is a limited range of available staining antibodies; furthermore, this procedure is time consuming and requires sophisticated techniques. Recently, liquid-based cytology (LBC) has become the standard technique for use in cytological analyses; however, this method requires a separate examination of cell sap while it is preserved. Additionally, the LBC reagent used for this type of analysis increases the occurrence of cellular contractions and the presence of cyst contents and artefacts such as those following mucolysis. [13] [14] [15] In cytological diagnosis, factors such as background mucus and cyst contents are important for determining the nature of lesions.
The increased use of pancreatic EUS-FNA has facilitated the improvement in biopsy using ultrasound. Nonetheless, further studies are warranted to improve the use of endoscopy. EUS-FNA can be used not only to diagnose benign or malignant pancreatic cancers but also to assess the sensitivity of molecular target drugs and chemotherapy.
Therefore, both histological biopsy and cytological diagnoses are required to enhance diagnostic precision in our hospital and other institutions.
Additionally, clinicians, pathologists, cytotechnologists and endoscopic engineers should cooperate in institutions to enhance diagnostic accuracy.
